The World Anti-Doping Agency (WADA) is pleased to publish details regarding the research projects approved to receive a total of USD 334,743 funding through the Agency’s 2024 Social Science Research ...
This Checklist is to guide the athlete and their physician on the requirements for a TUE application, related to Intravenous Infusions, that will allow the TUE Committee to assess whether the relevant ...
It is well known that the use performance-enhancing substances by athletes provide an unfair advantage and doping is contrary to the ‘the spirit of sport’. However, a randomised response surveys ...
Tesamorelin is a synthetic growth hormone-releasing hormone (GHRH) analogue, used for the reduction of excess abdominal fat in HIV-infected adults. As a GHRH analogue, it triggers the secretion of ...
Our main purpose of this study is to evaluate non-analytical factors that may influence the markers in the serum steroid profiles and endocrine profiles, which are indirect methods to detect doping ...
Clostebol (4-chloro-testosterone; 4-chloro-4-androsten-17-ol-3-one) is an anabolic androgenic steroid (AAS) derivative from testosterone. In humans, among the legitimate therapeutic indications of ...
The World Anti-Doping Agency (WADA) responds to a Reuters story of 7 August 2024 exposing a scheme whereby the U.S. Anti-Doping Agency (USADA) allowed athletes who had doped, to compete for years, in ...
The World Anti-Doping Agency (WADA) wishes to remind the global anti-doping community that experts interested in joining the Agency’s Expert Advisory Groups (EAGs) may submit applications to the ...
The World Anti-Doping Agency (WADA) invites stakeholders to the following webinar in September regarding the ongoing 2027 World Anti-Doping Code (Code) Update Process. Please note that the webinar is ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback